Key result
EDRF inhibition causes a ~37% drop in cardiac output during massive sympathetic activation in rabbits.
Why the study?
The role of endothelium-derived relaxing factor (EDRF) in modulating pulmonary and systemic hemodynamic responses and left ventricular dysfunction during massive sympathetic nervous system activation was unclear.
Does EDRF inhibition with L-NNA modulate hemodynamic responses, LV dysfunction, and pulmonary edema during massive sympathetic activation in rabbits?
Does EDRF inhibition with L-NNA modulate hemodynamic responses, LV dysfunction, and pulmonary edema during massive sympathetic activation in rabbits?
Inhibition of EDRF during massive sympathetic activation exacerbates LV dysfunction and increases pulmonary vascular resistance, leading to right ventricular failure which paradoxically protects against pulmonary edema.
Answers are grounded in this paper and cite their sources.
EDRF inhibition may exacerbate LV dysfunction during sympathetic activation in this model; leaves open relevance to human neurogenic stress or pulmonary edema syndromes.
This study was undertaken to determine whether endothelium-derived relaxing factor (EDRF) modulates the pulmonary and systemic hemodynamic responses to massive sympathetic nervous system (SNS) activation and, in so doing, also modulates the degree of SNS-induced left ventricular (LV) dysfunction and the likelihood for pulmonary edema formation. The SNS of 13 anesthetized untreated rabbits and 14 anesthetized rabbits pretreated with the EDRF inhibitor, N omega-nitro-L-arginine (L-NNA, 20 mg/kg), was massively activated with an intracisternal injection of veratrine. Pulmonary and systemic arterial pressures increased to the same extent in both groups, but LV end-diastolic pressure was significantly lower in untreated rabbits. During this time, cardiac output decreased by 37% in L-NNA pretreated rabbits compared with 8% in untreated animals. Peak systemic and pulmonary vascular resistances increased significantly in L-NNA rabbits, whereas only systemic vascular resistance increased significantly in untreated rabbits. However, this increase in systemic vascular resistance was threefold less than that observed for L-NNA-treated animals. Although the degree of LV dysfunction was greater in the L-NNA rabbits, pulmonary edema developed less frequently in this group. We suggest that when EDRF release is inhibited during massive SNS activity, pulmonary vascular resistance increases markedly, which causes the right ventricle to fail. We further suggest that the reduced right ventricular output maintains pulmonary microvascular pressure below levels required for edema development.
No takes yet. Share an insight, caveat, or question.
Pilati et al. (1995) studied Massive sympathetic nervous system activation (n=27). N omega-nitro-L-arginine (L-NNA) vs. Untreated was evaluated on Decrease in cardiac output. Inhibition of EDRF with L-NNA during massive sympathetic activation in rabbits led to a 37% decrease in cardiac output compared to an 8% decrease in untreated controls.
Synapse has enriched 10 related papers. Consider them for comparative context: